Related Experiment Video
Updated: Feb 22, 2026
Focal Cerebral Ischemia Model by Endovascular Suture Occlusion of the Middle Cerebral Artery in the Rat
Published on: February 5, 2011
The Pyk2/MCU pathway in the rat middle cerebral artery occlusion model of ischemic stroke
Kun Zhang1, Jiajia Yan2, Liang Wang2
1Neurology Department, The Second Hospital of Hebei Medical University, 215 West Heping Road, Shijiazhuang, Hebei 050000, China; Department of Biochemistry and Molecular and Cellular Biology, Georgetown University, 337 Basic Science Building, 3900 Reservoir Road, N.W., Washington D.C. 20057, USA.
Abstract:
Mitochondrial dysfunction caused by Ca2+ overload plays an important role in ischemia-induced brain damage. Mitochondrial calcium uniporter (MCU), located on the mitochondrial inner membrane, is the major channel responsible for mitochondrial Ca2+ uptake. Activated proline-rich tyrosine kinase 2 (Pyk2) can directly phosphorylate MCU, which enhances mitochondrial Ca2+ uptake in cardiomyocytes. It has been suggested that the Pyk2/MCU pathway may be a novel therapeutic target in stress-induced cellular apoptosis. In this study, we explored the role of the Pyk2/MCU pathway in the ischemic brain following a stroke injury. We found that the Pyk2/MCU pathway is activated in a rat cerebral ischemia model, and is responsible for mitochondrial dysfunction and neuronal apoptosis. Inhibiting the Pyk2/MCU pathway with a Pyk2 inhibitor (PF-431396) prevented mitochondrial Ca2+ overload, mitochondrial injury, proapoptotic protein release, and cell death. Interestingly, human urinary kallidinogenase (HUK) alleviated neuronal ischemic injury by inhibiting the Pyk2/MCU pathway, suggesting that the Pyk2/MCU pathway may be a protective target for ischemic stroke treatment.
Insights
The Pyk2/MCU pathway drives brain damage after stroke by causing mitochondrial dysfunction. Inhibiting this pathway with drugs like PF-431396 or HUK protects neurons and reduces injury.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Mitochondrial dysfunction, particularly calcium (Ca²⁺) overload, is a key factor in ischemia-induced brain damage.
- The mitochondrial calcium uniporter (MCU) is the primary channel for mitochondrial Ca²⁺ uptake.
- The proline-rich tyrosine kinase 2 (Pyk2) pathway's role in ischemic stroke is not fully understood.
Purpose of the Study:
- To investigate the role of the Pyk2/MCU pathway in the ischemic brain following stroke.
- To determine if the Pyk2/MCU pathway is a potential therapeutic target for ischemic stroke.
Main Methods:
- Utilized a rat model of cerebral ischemia.
- Administered a Pyk2 inhibitor (PF-431396) and human urinary kallidinogenase (HUK).
- Assessed mitochondrial Ca²⁺ uptake, mitochondrial injury, proapoptotic protein release, and neuronal cell death.
Main Results:
- The Pyk2/MCU pathway was found to be activated in the rat cerebral ischemia model.
- Activation of this pathway led to mitochondrial dysfunction and neuronal apoptosis.
- Inhibition of the Pyk2/MCU pathway with PF-431396 or HUK attenuated mitochondrial Ca²⁺ overload, injury, and neuronal death.
Conclusions:
- The Pyk2/MCU pathway is activated during ischemic stroke and contributes to neuronal damage.
- Inhibiting the Pyk2/MCU pathway offers a promising therapeutic strategy for ischemic stroke.
- Human urinary kallidinogenase (HUK) demonstrates neuroprotective effects by modulating this pathway.
